#covaxin — Public Fediverse posts

I'm really hoping the Indian government is collecting good surveillance data around the intranasal #Covaxin vaccine, and will be able to compute an effectiveness estimate against actual transmission soon. It's the world's first mass-deployed mucosal COVID vaccine. Pay attention.

I'm really hoping the Indian government is collecting good surveillance data around the intranasal #Covaxin vaccine, and will be able to compute an effectiveness estimate against actual transmission soon. It's the world's first mass-deployed mucosal COVID vaccine. Pay attention.

I'm really hoping the Indian government is collecting good surveillance data around the intranasal #Covaxin vaccine, and will be able to compute an effectiveness estimate against actual transmission soon. It's the world's first mass-deployed mucosal COVID vaccine. Pay attention.

I'm really hoping the Indian government is collecting good surveillance data around the intranasal #Covaxin vaccine, and will be able to compute an effectiveness estimate against actual transmission soon. It's the world's first mass-deployed mucosal COVID vaccine. Pay attention.

I'm really hoping the Indian government is collecting good surveillance data around the intranasal #Covaxin vaccine, and will be able to compute an effectiveness estimate against actual transmission soon. It's the world's first mass-deployed mucosal COVID vaccine. Pay attention.

After carefully evaluating the risks associated with all #COVID19 #vaccines available in #India, & after getting the expert opinion of specialists, I got double #vaccinated with #BharatBiotech's #Covaxin in '21. My family & 2 of my friends did the same.

Except for 1 friend, the rest of us all eventually got a mild form of #COVID in '22, which we recovered from (2 ~ 5 days). So, I was planning to avoid the booster dose.

Now, I don't mind getting the #nasalvaccine, because it is VERY SAFE! 👍 👌 👏

After carefully evaluating the risks associated with all #COVID19 #vaccines available in #India, & after getting the expert opinion of specialists, I got double #vaccinated with #BharatBiotech's #Covaxin in '21. My family & 2 of my friends did the same.

Except for 1 friend, the rest of us all eventually got a mild form of #COVID in '22, which we recovered from (2 ~ 5 days). So, I was planning to avoid the booster dose.

Now, I don't mind getting the #nasalvaccine, because it is VERY SAFE! 👍 👌 👏

After carefully evaluating the risks associated with all #COVID19 #vaccines available in #India, & after getting the expert opinion of specialists, I got double #vaccinated with #BharatBiotech's #Covaxin in '21. My family & 2 of my friends did the same.

Except for 1 friend, the rest of us all eventually got a mild form of #COVID in '22, which we recovered from (2 ~ 5 days). So, I was planning to avoid the booster dose.

Now, I don't mind getting the #nasalvaccine, because it is VERY SAFE! 👍 👌 👏

Bravo #BharatBiotech! 👏👏

The ONLY way to deal with #COVID #vaccine hesitancy among citizens is by making vaccines SAFER & by being VERY TRANSPARENT about their #sideeffects, and NOT by the outrageous #vaccinemandates!

Bharat Biotech's #Covaxin is among the safest #COVID19 #vaccines. It is a whole-virion inactivated vaccine, & has reported very few adverse events.

Now, Bharat Biotech has released AN EVEN SAFER #nasalvaccine, the non-injected nasal version of Covaxin! 👏

https://www.indiatoday.in/coronavirus-outbreak/story/bharat-biotech-nasal-covid-vaccine-out-as-booster-dose-2312377-2022-12-22

Bravo #BharatBiotech! 👏👏

The ONLY way to deal with #COVID #vaccine hesitancy among citizens is by making vaccines SAFER & by being VERY TRANSPARENT about their #sideeffects, and NOT by the outrageous #vaccinemandates!

Bharat Biotech's #Covaxin is among the safest #COVID19 #vaccines. It is a whole-virion inactivated vaccine, & has reported very few adverse events.

Now, Bharat Biotech has released AN EVEN SAFER #nasalvaccine, the non-injected nasal version of Covaxin! 👏

https://www.indiatoday.in/coronavirus-outbreak/story/bharat-biotech-nasal-covid-vaccine-out-as-booster-dose-2312377-2022-12-22

Bravo #BharatBiotech! 👏👏

The ONLY way to deal with #COVID #vaccine hesitancy among citizens is by making vaccines SAFER & by being VERY TRANSPARENT about their #sideeffects, and NOT by the outrageous #vaccinemandates!

Bharat Biotech's #Covaxin is among the safest #COVID19 #vaccines. It is a whole-virion inactivated vaccine, & has reported very few adverse events.

Now, Bharat Biotech has released AN EVEN SAFER #nasalvaccine, the non-injected nasal version of Covaxin! 👏

https://www.indiatoday.in/coronavirus-outbreak/story/bharat-biotech-nasal-covid-vaccine-out-as-booster-dose-2312377-2022-12-22

Thanks you - but these are Concerns along with your Clarification Statements and not False Statements with Fact Checks...
---
RT @BharatBiotech
COVAXIN® - Fact Check- Issued in Public Interest

#Covaxin #COVID19Vaccine #COVID19 #BharatBiotech
https://twitter.com/BharatBiotech/status/1478770428562706436

Thanks you - but these are Concerns along with your Clarification Statements and not False Statements with Fact Checks...
---
RT @BharatBiotech
COVAXIN® - Fact Check- Issued in Public Interest

#Covaxin #COVID19Vaccine #COVID19 #BharatBiotech
https://twitter.com/BharatBiotech/status/1478770428562706436

---
RT @bsindia
The multi-dose vial policy saves money for procurement agencies by reducing the cold chain logistics

@sohinidastweets reports

#Covaxin #BharatBiotech #CoronavirusVaccine
https://mybs.in/2ZjoRlQ
https://twitter.com/bsindia/status/1473119783315025926

RT @[email protected]

But this #Covaxin data is from a study conducted at and by AIIMS!

Did you expect Lancet to revise the figure upwards to appease the likes of you? Or did you want AIIMS to report false data in “national interest”? 😂🤣 https://twitter.com/kanwalsibal/status/1463388183630995459

🐦🔗: https://twitter.com/rakeshfilm/status/1463811638088253442

RT @[email protected]

.#India’s indigenous #Covaxin has not been supplied to 13 states, all of them from north-east India, and union territories, from the beginning of the #COVID vaccination drive in January 2021 till now; via @[email protected] https://www.nationalheraldindia.com/india/arbitrary-vaccine-policy-continues-13-statesuts-not-given-covaxin-at-all-vaccine-shortage

🐦🔗: https://twitter.com/JatinPaul/status/1421114348957626376

RT @[email protected]

.#India’s indigenous #Covaxin has not been supplied to 13 states, all of them from north-east India, and union territories, from the beginning of the #COVID vaccination drive in January 2021 till now; via @[email protected] https://www.nationalheraldindia.com/india/arbitrary-vaccine-policy-continues-13-statesuts-not-given-covaxin-at-all-vaccine-shortage

🐦🔗: https://twitter.com/JatinPaul/status/1421114348957626376

13 states/UTs - Chandigarh, Manipur, Meghalaya, Mizoram, Arunachal Pradesh, Nagaland, Ladakh, Andaman and Nicobar Islands, Dadra and Nagar Haveli, Daman and Diu, Lakshadweep, Sikkim and Puducherry have not got #COVAXIN shots at all. #vaccines

https://www.nationalheraldindia.com/india/arbitrary-vaccine-policy-continues-13-statesuts-not-given-covaxin-at-all-vaccine-shortage

RT @[email protected]

#India’s indigenous #vaccine, #Covaxin has not been supplied to 13 states, all of them from north-east India, and union territories, from beginning of #vaccinationdrive in January 2021 until now @[email protected] https://www.nationalheraldindia.com/india/arbitrary-vaccine-policy-continues-13-statesuts-not-given-covaxin-at-all-vaccine-shortage

🐦🔗: https://twitter.com/NH_India/status/1421089878918508547

RT @[email protected]

Though #Covaxin was produced in partnership between #ICMR and #BBIL, ICMR would get only five per cent royalty on net sales on a half-yearly basis, the #HealthMinistry has stated. #COVID19 #Pandemic @[email protected] https://www.nationalheraldindia.com/india/bharat-biotech-has-supplied-only-545-crore-doses-of-covaxin-since-january

🐦🔗: https://twitter.com/NH_India/status/1417498501567688712

#BharatBiotech Releases Long-Awaited Covaxin's Phase 3 Trial Data.

According to the paper, #Covaxin is:

77.8% efficacious against symptomatic #COVID-19 two weeks after the second dose.

93.4% efficacious against severe COVID-19.

65.2% efficacious against symptomatic COVID-19 caused by the #DeltaVariant (B.1.617.2).

https://thewire.in/health/covaxin-bharat-biotech-phase-3-trial-data

#BharatBiotech Releases Long-Awaited Covaxin's Phase 3 Trial Data.

According to the paper, #Covaxin is:

77.8% efficacious against symptomatic #COVID-19 two weeks after the second dose.

93.4% efficacious against severe COVID-19.

65.2% efficacious against symptomatic COVID-19 caused by the #DeltaVariant (B.1.617.2).

https://thewire.in/health/covaxin-bharat-biotech-phase-3-trial-data

Leave Petrol... Wait for the Day when a bottle of Water will cost more than Rs 150 in The Tyrant's #NewIndia...
---
RT @pti_news
Supply price of #Covaxin to Centre at Rs 150 per dose not sustainable in the long run: Bharat Biotech
https://twitter.com/PTI_News/status/1404734278596907008

Leave Petrol... Wait for the Day when a bottle of Water will cost more than Rs 150 in The Tyrant's #NewIndia...
---
RT @pti_news
Supply price of #Covaxin to Centre at Rs 150 per dose not sustainable in the long run: Bharat Biotech
https://twitter.com/PTI_News/status/1404734278596907008

I can't understand this, #Covaxin, research for which was funded by our tax is priced the most while the imported vaccines are cheaper! Just how much goes towards electoral bonds?
https://www.ndtv.com/india-news/covishield-at-780-covaxin-at-1-410-sputnik-v-at-1-145-maximum-price-that-can-be-charged-for-vaccines-by-private-hospitals-2459353

I can't understand this, #Covaxin, research for which was funded by our tax is priced the most while the imported vaccines are cheaper! Just how much goes towards electoral bonds?
https://www.ndtv.com/india-news/covishield-at-780-covaxin-at-1-410-sputnik-v-at-1-145-maximum-price-that-can-be-charged-for-vaccines-by-private-hospitals-2459353

日本にも上陸した　#インド変異株 （#二重変異株 ）。
インドBharat Biotech社のワクチン「#Covaxin 」なら効くかもしれない（が日本での接種は無理）
ICMR says Covaxin effective in neutralising double mutant variant
https://youtu.be/7EY2rhiM30c

இந்தியா : இன்று மாலை வரை 60.35 லட்சம் பேருக்கு கொரோனா தடுப்பூசி போடப்பட்டுள்ளது

https://www.patrikai.com/till-today-evening-60-35-lakhs-were-corona-vaccinated-in-india/ #today #IndiaFightsCorona #CoronaVaccine #covishield #COVAXIN

பிப்ரவரி 1ம் தேதி முதல் பிற துறை சார்ந்த முன்களப் பணியாளர்களுக்கு கொரோனா தடுப்பூசி: அமைச்சர் விஜயபாஸ்கர்

https://www.patrikai.com/corona-vaccine-for-other-field-frontline-personnel-from-february-1-says-minister-vijayabaskar/ @[email protected] #CoronaVaccine #TNCoronaUpdate #February #vaccinationCovid #Covaxin #Covishield

“இன்று முதல் கொரோனா தடுப்பூசி”: மத்தியில் பிரதமர் மோடி, மாநிலத்தில் முதல்வர் பழனிசாமி இன்று தொடங்கி வைக்கின்றனர்...

https://www.patrikai.com/corona-vaccine-from-today-prime-minister-modi-chief-minister-edappadi-palaniswami-starts-today/ @[email protected] @[email protected] @[email protected] @[email protected] @[email protected] @[email protected] #Covaxin #Covishield #VaccineForIndia #vaccinationCovid

கொரோனா தடுப்பூசி குறித்து சந்தேகமா? பொது சுகாதாரத்துறை தரும் விளக்கம் இதோ...

https://www.patrikai.com/doubts-about-the-corona-vaccine-explanation-given-by-the-public-health-department/ @[email protected] @[email protected] #CoronaVaccine #VaccineForIndia #Covaxin #Covishield

India’s clinical trial rules provide for audio-video recording when obtaining informed consent from illiterate participants. Several #COVAXIN trial participants in Bhopal’s low-income areas say they had not seen any recording at the trial https://bit.ly/2LfAEjw

ஹரியானா அமைச்சருக்கு 'கோவாக்ஸின்' பலன் தராதது ஏன்? - பாரத் பயோடெக் விளக்கம் https://bit.ly/3qxu1J6
#Covaxin #HaryanaMinister #Coronavirus

கொரோனா தடுப்பூசி மருத்துவ பரிசோதனையில் பங்கேற்க விரும்பும் தன்னார்வலர்கள் கவனத்திற்கு..!

#COVAXIN | #COVID19 | #SRM | #TNFightsCorona | #Coronavirus | #CoronaVaccine

கொரோனா தடுப்பூசி மருத்துவ பரிசோதனையில் பங்கேற்க விரும்பும் தன்னார்வலர்கள் கவனத்திற்கு..!

#COVAXIN | #COVID19 | #SRM | #TNFightsCorona | #Coronavirus | #CoronaVaccine

#BREAKING | கொரோனா தடுப்பூசி கோவாக்சின் மனிதர்களுக்கு செலுத்தப்பட்டது

#CoronaVirus | #Covid_19 | #Covaxin

RT @[email protected]

The Indian Council of Medical Research (@[email protected]) plans to launch its #COVID19 vaccine #Covaxin made in collaboration with Hyderabad-based Bharat Biotech International Limited (BBIL) by August 15 for public use. @[email protected] #BOOMFactCheck #vaccine

https://zcu.io/6Yg6